Targeting B-cell maturation antigen (BCMA) with GSK2857916 antibody-drug conjugate provides durable responses in patients (Pts) with heavily-pretreated relapsed/refractory multiple myeloma (RRMM): Preliminary results from study BMA117159 Meeting Abstract
| Authors: | Popat, R.; Trudel, S.; Lendvai, N.; Voorhees, P.; Reeves, B.; Libby, E.; Richardson, P.; Anderson, L. Jr; Sutherland, H.; Yong, K.; Hoos, A.; Gorczyca, M.; Lahiri, S.; He, Z.; Jewell, R.; Opalinska, J.; Cohen, A. |
| Abstract Title: | Targeting B-cell maturation antigen (BCMA) with GSK2857916 antibody-drug conjugate provides durable responses in patients (Pts) with heavily-pretreated relapsed/refractory multiple myeloma (RRMM): Preliminary results from study BMA117159 |
| Meeting Title: | 1st European Myeloma Network Meeting |
| Journal Title: | Haematologica |
| Volume: | 103 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Apr 19-21 |
| Meeting Location: | Turin, Italy |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2018-04-18 |
| Start Page: | 30 |
| Language: | English |
| ACCESSION: | WOS:000431395800065 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P36 -- Source: Wos |
MSK Authors
-
106Lendvai